Clinical outcomes of dabigatran use in patients with non-valvular atrial fibrillation and weight >120 kg.
Sign Up to like & getrecommendations! Published in 2021 at "Thrombosis research"
DOI: 10.1016/j.thromres.2021.11.007
Abstract: BACKGROUND Patients with obesity were underrepresented in studies evaluating the safety and effectiveness of direct oral anticoagulants (DOAC) in patients with non-valvular atrial fibrillation (NVAF). This study compared clinical outcomes in patients with NVAF and… read more here.
Keywords: atrial fibrillation; use; valvular atrial; dabigatran use ... See more keywords